ARKK ARK Innovation ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| TSLA | 10.54% |
| CRSP | 6.30% |
| TEM | 5.02% |
| SHOP | 4.74% |
| COIN | 4.32% |
| HOOD | 4.27% |
| CRCL | 4.25% |
| AMD | 4.05% |
| ROKU | 3.95% |
| RBLX | 3.55% |
ETF Analysis
Fund Overview
ARK Innovation ETF (ARKK) currently reports 43 stock positions (subject to change), placing it in the selectively diversified range by holdings breadth. The top line-up is TSLA (10.54%), CRSP (6.30%), TEM (5.02%), with TSLA as the largest single weight at 10.54%. Together, the top three holdings account for 21.86%, which points to a relatively flat weight distribution where no single cluster of names dominates outcomes. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.
Profitability & Capital Efficiency
Assessing the quality of returns on invested capital, ROIC is -9.40%, WACC is 14.85%, and the economic spread is -24.25%. On balance, the portfolio's businesses are not clearing their capital cost hurdle, meaning reinvestment may be diluting rather than compounding value. Supporting metrics show ROE at -20.78% and ROA at -1.70%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that likely needs operating improvement before returns quality can be considered durable.
Valuation
The current pricing of the underlying holdings reads trailing P/E of 60.02, forward P/E of 41.02, PEG of 2.20. A meaningful compression from trailing to forward P/E implies analysts are projecting earnings growth that could re-rate the portfolio favorably if delivered. The PEG ratio signals a portfolio priced at reasonable growth-adjusted value — adequate for the earnings outlook, without offering an obvious margin of safety. At 4.82, the aggregate current ratio reflects strong balance sheet liquidity across the portfolio. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.
Margins & Cash Generation
Looking at margins from gross to free cash flow, gross margin sits at 42.44%, operating margin at -44.37%, and free cash flow margin at 19.17%. Gross margins are constructive — not exceptional, but indicative of businesses with reasonable unit economics. Near-zero or negative operating margins point to holdings where growth investment is currently prioritized over near-term profitability. The portfolio's cash conversion is solid — a sign that operating profits are translating into real liquidity at the fund level. Together, these margins describe a portfolio where business quality varies — and where macro or sector headwinds could disproportionately impact the weaker-margin holdings.
Growth & Forward Outlook
Projected 12-month EPS growth of 46.4% adds a powerful forward signal — analyst consensus expects earnings to accelerate materially, which, if delivered, could make current multiples look increasingly modest. Zooming out from the valuation discussion, TTM revenue growth of 39.07% pointing to sustained and broad-based revenue growth within the basket, while the estimated 12-month price change of 41.31%, where analyst targets indicate a strong re-rating opportunity from current prices. Anchoring to reported revenues provides discipline; analyst price targets add context about how the market currently values that operating reality. The path to realizing analyst-implied returns runs through revenue execution, margin stability, and a macro environment that doesn't undermine either. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyTaken together, the metrics present a favorable setup — not without risk, but with enough quality and momentum to support a positive view.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.